Acetaminophen; ibuprofen sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for acetaminophen; ibuprofen sodium and what is the scope of patent protection?
Acetaminophen; ibuprofen sodium
is the generic ingredient in one branded drug marketed by Hikma and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Acetaminophen; ibuprofen sodium has sixty-five patent family members in thirty countries.
One supplier is listed for this compound.
Summary for acetaminophen; ibuprofen sodium
International Patents: | 65 |
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 7 |
DailyMed Link: | acetaminophen; ibuprofen sodium at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for acetaminophen; ibuprofen sodium
Generic Entry Date for acetaminophen; ibuprofen sodium*:
Constraining patent/regulatory exclusivity:
NEW PRODUCT Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for acetaminophen; ibuprofen sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, Los Angeles | Phase 4 |
Northwestern University | Phase 4 |
Nemours Children's Clinic | Early Phase 1 |
Pharmacology for acetaminophen; ibuprofen sodium
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for acetaminophen; ibuprofen sodium
US Patents and Regulatory Information for acetaminophen; ibuprofen sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | COMBOGESIC IV | acetaminophen; ibuprofen sodium | SOLUTION;INTRAVENOUS | 215320-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for acetaminophen; ibuprofen sodium
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Eurasian Patent Organization | 201790223 | ВОДНЫЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ ПАРАЦЕТАМОЛ И ИБУПРОФЕН | ⤷ Sign Up |
Serbia | 60289 | VODENA FORMULACIJA KOJA SADRŽI PARACETAMOL I IBUPROFEN (AQUEOUS FORMULATION COMPRISING PARACETAMOL AND IBUPROFEN) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2016008546 | ⤷ Sign Up | |
Japan | 2017522382 | パラセタモール及びイブプロフェンを含む水性配合物 | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.